Deep, focused next-technology sequencing has revealed that subclonal mutations (i.e., Those people existing in only a portion of tumor cells) may be detected for all driver genes and are linked to speedy disease development and very poor outcome.11–13 This is especially suitable for TP53 mutations presented the fact that, as https://edwardz075vem3.theideasblog.com/profile